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Abstract 
Na+(K+)/H+ exchanger 6 (NHE6) on synaptic vesicle (SV) is critical for the presynaptic regulation of quantal size at 
the glutamatergic synapses by converting the chemical gradient (ΔpH) into membrane potential (Δψ) across the SV 
membrane. We recently found that NHE6 directly interacts with secretory carrier membrane protein 5 (SCAMP5), and 
SCAMP5-dependent recruitment of NHE6 to SVs controls the strength of synaptic transmission by modulation of 
quantal size of glutamate release at rest. It is, however, unknown whether NHE6 recruitment by SCAMP5 plays a role 
during synaptic plasticity. Here, we found that the number of NHE6-positive presynaptic boutons was significantly 
increased by the chemical long-term potentiation (cLTP). Since cLTP involves new synapse formation, our results indi-
cated that NHE6 was recruited not only to the existing presynaptic boutons but also to the newly formed presynaptic 
boutons. Knock down of SCAMP5 completely abrogated the enhancement of NHE6 recruitment by cLTP. Interest-
ingly, despite an increase in the number of NHE6-positive boutons by cLTP, the quantal size of glutamate release at 
the presynaptic terminals remained unaltered. Together with our recent results, our findings indicate that SCAMP5-
dependent recruitment of NHE6 plays a critical role in manifesting presynaptic efficacy not only at rest but also during 
synaptic plasticity. Since both are autism candidate genes, reduced presynaptic efficacy by interfering with their 
interaction may underlie the molecular mechanism of synaptic dysfunction observed in autism.
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Introduction
NHE6 is an endosomal subtype of monovalent  Na+(K+)/
H+ exchangers (NHEs) that transports  H+ ion from the 
luminal to cytoplasmic part, and  Na+(K+) ion to oppo-
site direction at intracellular vesicles such as endosomes 
and synaptic vesicles (SVs) [1]. Vacuolar-type  H+-ATPase 
and NHE6, with other ion channels/transports on SVs, 
regulate a proton electrochemical gradient (ΔμH+), con-
sisting of the chemical gradient (ΔpH) and membrane 
potential (Δψ) across the SV membrane to fill SVs with 
neurotransmitters [2]. Since NHE activity dissipates ΔpH 
and increases Δψ across the SV membrane at the presyn-
aptic terminals, the uptake of an anionic neurotransmit-
ter such as glutamate into SVs is mainly promoted by Δψ 
than by ΔpH [3–5]. Since loss-of-function mutations of 
NHE6 are implicated in various neurodevelopmental, 
neuropsychiatric and neurodegenerative diseases includ-
ing autism spectrum disorder (ASD), Christianson syn-
drome, X-linked intellectual disability, and Alzheimer’s 
disease, the regulation of NHE6 function and trafficking 
is critical for underpinning neurophysiological basis of 
these diseases [1, 6–10].
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One of five secretory carrier membrane proteins 
(SCAMPs) family, SCAMP5 which is enriched in the 
brain, especially in SVs [11], plays a critical role in SV 
endocytosis during high neuronal activity [12] and SV 
release site clearance within the active zone at presyn-
aptic terminals for regulating short-term depression of 
SV exocytosis [13]. It also has been implicated in sev-
eral neurodevelopmental and neurodegenerative dis-
eases such as ASD and Parkinson’s disease (PD) [14, 15], 
SCAMP5 is considered to be engaged in the regulation 
of function and trafficking of SV proteins for appropriate 
synaptic transmission.
We recently found that the direct interaction between 
SCAMP5 and NHE6 regulates the recruitment of NHE6 
to SVs for controlling the luminal pH of SVs and subse-
quent the amount of neurotransmitter release at glu-
tamatergic synapses. In SCAMP5 knockdown (KD) 
neurons, NHE6 fails to be localized at presynaptic ter-
minals and dispersed along the axon because axonal traf-
ficking of NHE6 is drastically inhibited. The failure of 
presynaptic localization of NHE6 in SCAMP5 KD neu-
rons leads to the hyperacidification of SVs’ lumen, fol-
lowed by a significant reduction in the glutamate quantal 
size at individual presynaptic boutons. Physiological 
defects caused by SCAMP5 KD are also observed with 
similar extents in NHE6 knockout neurons, indicating 
that the decreased glutamate quantal size at the presyn-
aptic side results from disturbed localization of NHE6 to 
SVs due to the impaired interaction between SCAMP5 
and NHE6 in SCAMP5 KD neurons [16].
Activity-dependent neuronal modification carries 
the changes in synaptic strength including presynaptic 
release efficacy [17, 18]. Since presynaptic localization 
of NHE6 is important for presynaptic regulation of glu-
tamate quantal size [16], we hypothesized that modu-
lating NHE6 trafficking to the presynaptic terminals by 
SCAMP5 could be one of the molecular mechanisms 
responsible for controlling presynaptic efficacy during 
synaptic plasticity. Here, we found that the number of 
NHE6-containing presynaptic boutons was significantly 
increased by a chemical long-term potentiation (cLTP) in 
cultured hippocampal neurons and that was completely 
abrogated by SCAMP5 KD. Interestingly, despite an 
increase in the number of NHE6-positive boutons, cLTP 
did not increase the quantal size of glutamate release at 
the individual presynaptic boutons.
Together with our previous research data [16], these 
results indicate that the interaction between SCAMP5 
and NHE6 is critical for regulating NHE6 localization 
to SVs during LTP as well as resting state to adjust the 
presynaptic efficacy at glutamatergic synapses. Since 
both NHE6 and SCAMP5 are known as the candidate 
genes for autism, and some of non-sense mutations of 
NHE6 found in neuropsychiatric disorders fail to associ-
ate with SCAMP5 [16], our results suggest an intriguing 
possibility that defects in NHE6 recruitment into SVs by 
impaired interaction between NHE6 and SCAMP5 influ-
ence the filling of SVs with neurotransmitters, which 
might underlie the synaptic dysfunction phenotype 




Small hairpin RNA (shRNA) targeting SCAMP5 were 
made as previously reported [13, 16]. mCherry-tagged 
synaptophysin plasmid was made from GFP-synapto-
physin (kindly provided by Dr. Jane Sullivan, University 
of Washington). iGluSnFR [19] plasmid was purchased 
from Addgene (Plasmid #41732). The fidelity of all con-
structs was verified by DNA sequencing.
Antibodies
Anti-rabbit SLC9A6 (LS-B13548-50; LifeSpan Bio-
Sciences, Seattle, WA) was used in the experiment. Alexa 
Fluor secondary antibodies were purchased from Thermo 
Fisher Scientific (Waltham, MA).
Rat primary hippocampal neuron culture
Hippocampal neurons were prepared as previously 
described [16, 20]. Briefly, dissociated hippocampal neu-
rons from SD embryonic day 18 fetal rats were treated 
with papain and plated on poly-d-lysine-coated 18-mm 
glass coverslips in a 60-mm Petri dish with plating 
medium (minimum Eagle’s medium; Invitrogen, 0.6% 
glucose, 1  mM pyruvate, 2  mM l-glutamine, 10% fetal 
bovine serum; Hyclone) after trituration with a pol-
ished half-bore Pasteur pipette. After 3  h, the plating 
medium was replaced by neurobasal medium (Invitro-
gen) with 2% B-27 (Invitrogen), 0.5 mM l-glutamine and 
4  μM 1-b-d-cytosine-arabinofuranoside (Ara-C; Sigma-
Aldrich). The 1/2 of the medium was replaced by a new 
neurobasal medium with B-27 and l-glutamine at DIV 4, 
7 and 14.
Neuron transfection and image acquisition
Cultured hippocampal neurons were transfected by using 
the calcium-phosphate method as previously described 
[13, 16]. Briefly, at DIV 8–10, 6 μg cDNA, 9.3 μl of 2 M 
 CaCl2 were mixed in distilled water to a final volume of 
75 μl and added to 75 μl 2XBBS (50 mM BES, 280 mM 
NaCl, and 1.5 mM  Na2HPO4, pH 7.1). The mixture solu-
tion was incubated for 20  min at room temperature 
and added to neurons in transfection medium (mini-
mum Eagle’s medium, 1  mM pyruvate, 0.6% glucose, 
10  mM l-glutamine, and 10  mM HEPES, pH 7.65) for 
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50–60  min at 37  ℃, 5%  CO2 incubator. After incuba-
tion, the transfection medium was replaced with wash-
ing medium (minimum Eagle’s medium, 1 mM pyruvate, 
0.6% glucose, 10  mM l-glutamine, and 10  mM HEPES, 
pH 7.35) for 20–30 min at 37 ℃, 5%  CO2 incubator and 
again changed with the original neurobasal medium. 
Transfected neurons on coverslips were mounted and 
imaged by Olympus IX71 fluorescence microscope, a 
60× 1.35 N.A. oil-immersion lens using an Andor Zyla-
5.5-CL3 sCMOS camera (Andor Technologies, Belfast, 
Northern Ireland) driven by MetaMorph imaging soft-
ware (Universal Imaging Corporation, West Chester, PA). 
Images were analyzed by ImageJ/FIJI (NIH, Bethesda, 
MD) software.
Immunocytochemistry
For immunostaining NHE6 proteins, neurons were fixed 
in 3% glyoxal with 20% absolute ethanol and 7.5% ace-
tic acid for 1 h at room temperature and quenched with 
100 mM  NH4Cl solution for 30 min at room temperature. 
After that, cells were permeabilized and blocked with 
2.5% BSA and 0.1% Triton X-100/PBS for 15 min at room 
temperature. Cells were incubated with primary antibod-
ies in blocking solution for 3  h at 37 ℃ and with Alexa 
Fluor-conjugated secondary antibody in blocking solu-
tion for 45 min at 37 ℃. After immunostaining, cells on 
coverslips were mounted on a slide glass and fluorescent 
images were acquired.
Image acquisition of glutamate release using iGluSnFR
iGluSnFR signals were obtained as previously described 
[16, 21]. Briefly, transfected neurons with iGluSnFR 
at DIV 14–16 were mounted in a perfusion/stimula-
tion chamber (Chamlide, South Korea) on the stage of 
a Nikon Eclipse Ti-U fluorescence microscope (Nikon, 
Tokyo, Japan) with a 40× and 1.0  N.A. oil-immer-
sion lens at 35 ℃ in Tyrode’s solution (136  mM NaCl, 
2  mM  CaCl2, 2.5  mM KCl, 2  mM  MgCl2, 10  mM glu-
cose, 10  mM HEPES, pH 7.4, 285–290  mOsm). Stream 
images were obtained at 100 Hz with an Andor iXon 897 
EMCCD camera (Andor Technologies) with cropped 
mode, driven by MetaMorph Imaging Software (Uni-
versal Imaging Corporation). To measure the iGluSnFR 
response of spontaneous glutamate release, 12 trials of 
500 frames (100  Hz imaging acquisition) were acquired 
with a 60 s interval in the presence of 1 μM TTX to pre-
vent neuronal firing.
Induction of cLTP and FM 1–43 uptake/destaining
cLTP was induced by forskolin in cultured hippocampal 
neurons as previously described [22]. Briefly, forskolin 
(50 μM) or DMSO (as a control) was treated to cultured 
hippocampal neurons at DIV 14–16 during 30  min in 
at 37  ℃  CO2 incubator for inducing cLTP. After that, 
FM 1–43 loading/unloading experiment was performed 
or endogenous NHE6 protein was immunostained. For 
FM 1–43 uptake, neurons at DIV14–16 were stimulated 
with 300 APs at 10 Hz in the presence of 10 μM FM 1–43 
(Invitrogen, Carlsbad, CA) and 50  μM APV in Tyrode’s 
solution (136  mM NaCl, 2  mM  CaCl2, 2.5  mM KCl, 
2  mM  MgCl2, 10  mM glucose, 10  mM HEPES, pH 7.4, 
285–290 mOsm), kept in additional 30 s after stimulation 
for labeling post-stimulus endocytosed synaptic vesi-
cles. Cells were washed with low-Ca2+ and high-Mg2+ 
Tyrode’s solution (119 mM NaCl, 0.5 mM  CaCl2, 2.5 mM 
KCl, 10 mM  MgCl2, 30 mM glucose, 25 mM HEPES, pH 
7.4, 285–290  mOsm) with 1  mM ADVASEP-7 (Sigma-
Aldrich, ST. Louis, MO) for the removal of cell surface-
bound FM 1–43 dye. After washing period (5 min), 1200 
APs at 10  Hz were applied to neurons for destaining of 
loaded FM 1–43. The imaging was obtained by Olym-
pus IX71 fluorescence microscope, a 60× 1.35 N.A. oil-
immersion lens using an Andor Zyla-5.5-CL3 sCMOS 
camera (Andor Technologies) driven by MetaMorph 
imaging software (Universal Imaging Corporation) in 
closed perfusion/stimulation chamber (Chamlide) and 
perfused continuously with respective solution at 35 ℃ 
by using MPS-8 multi-valve perfusion system (Chamlide) 
at 0.5–1.0 mL/min. Images were analyzed by ImageJ/FIJI 
(NIH) software and decay time constant (τ) was analyzed 
and calculated by fitting with single exponential function 
by using Origin 9 software (OriginLab).
Statistical analysis
For analysis of protein colocalization, Manders’ colocaliza-
tion coefficients (MCC) were calculated using ImageJ/FIJI 
(NIH) with the JACoP plug-in function (https ://image j.nih.
gov/ij/plugi ns/track /jacop .html). Average of MCC value 
of each sample was compared by One-way ANOVA with 
LSD post hoc test. Values are indicated as mean ± SEM. 
Quantitative measurements of FM 1–43 and iGluSnFR 
responses from individual boutons were obtained using 
ImageJ/FIJI (NIH). Individual rectangular regions of inter-
est (ROIs) were drawn around the synaptic boutons and 
marked by hand, then obtained by averaging pixel inten-
sities of selected areas and average intensities were calcu-
lated. Large puncta, the clusters of smaller synapses, were 
excluded from the selection procedure. The center of 
intensity of each synapse was calculated to correct for any 
image shifts throughout the experiment. Fluorescence was 
expressed in intensity units that correspond to fluorescence 
values averaged over all pixels within the region of interest. 
Data were collected from 20 to 30 boutons in each cover-
slip and “n” stands for the number of boutons or coverslips 
in FM 1–43 and iGluSnFR experiments. iGluSnFR data 
were presented as mean ± SD compared by paired samples 
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t-test and analyzed by using Origin 9 software (OriginLab 
Corporation, Northampton, MA) and SPSS Statistics 23 
(IBM, Armonk, NY). Significance of all data is reported as 
*p < 0.05, **p < 0.01, ***p < 0.001.
Results
Chemical LTP induced by forskolin increases presynaptic 
release efficacy and the number of functional presynaptic 
boutons
Our recent data showed that SCAMP5, which is highly 
enriched in SVs and involved in vesicular membrane traf-
ficking, regulates the recruitment of NHE6 to SVs by 
their direct interaction [16]. Since presynaptic efficacy is 
enhanced by activity-dependent neuronal modification 
[23] and the proper localization of NHE6 is important 
for presynaptic regulation of glutamate quantal size [16], 
we wondered that an increase in synaptic activity would 
affect NHE6 recruitment to the presynaptic terminals. To 
address this possibility, we induced a cLTP in cultured hip-
pocampal neurons by using forskolin, an adenylyl cyclase 
activator, which is known to induce presynaptic LTP by 
activating cAMP/PKA signaling pathway [18, 24–26].
To evaluate the induction of a cLTP in cultured neu-
rons, we performed N-(3-triethylammoniumpropyl)-4-
(4-(dibutylamino)styryl) pyridinium dibromide (FM1–43) 
loading and destaining assay after treatment of forsko-
lin or dimethyl sulfoxide (DMSO). Cultured hippocam-
pal neurons at days in vitro (DIV) 14–16 were stimulated 
with 300 action potentials (APs) at 10 Hz in the presence 
of FM 1–43 and were washed for the removal of cell sur-
face-bound FM 1–43. After washing period, neurons were 
stimulated with 1200 APs at 10 Hz for destaining of loaded 
FM 1–43 (Fig. 1a).
We found that the application of forskolin to cultured 
hippocampal neurons increased the amount of uptake of 
FM 1–43, and accelerated its destaining rate, which repre-
sents the increase in recycling SV pool size and the release 
probability of SV release (Fig. 1b–f). In addition, forskolin 
treatment significantly increased the number of presyn-
aptic boutons (Fig. 1g, h). In our previous study, using FM 
1–43 and retrospective immunostaining of a postsynap-
tic SH3 and multiple ankyrin repeat domains (SHANK), 
we confirmed that the newly formed presynaptic boutons 
were functional, and were juxtaposed to SHANK-positive 
postsynaptic structures, indicating that cLTP increases the 
number of bona fide functional synapses [22].
cLTP significantly increases the number of NHE6‑positive 
presynaptic boutons, which is completely inhibited 
by SCAMP5 KD
To investigate whether the recruitment of NHE6 to the 
presynaptic terminals is altered in an activity-dependent 
manner and this mechanism is mediated by SCAMP5, 
cultured hippocampal neurons were co-transfected with 
synaptophysin (SYP) and small hairpin RNA (shRNA)-
targeting SCAMP5 to suppress the endogenous SCAMP5 
expression or scrambled RNA (scrRNA) as a control 
(Fig.  2a) and endogenous NHE6 proteins were immu-
nostained after cLTP induction.
The number of presynaptic boutons was increased in 
both control and SCAMP5 KD neurons (Fig. 2a–c), indi-
cating that SCAMP5 KD did not affect cLTP-induced 
increase in the number of presynaptic boutons. When 
counting the number of SYP overlapping with NHE6, 
there is a significant increase in SYP/NHE6 overlap 
in control neurons (0.522 ± 0.039 in − cLTP of CTL; 
0.761 ± 0.037 in + cLTP of CTL, Fig.  2a–e). This means 
that NHE6 was recruited not only to the existing presyn-
aptic boutons that previously had no NHE6, but also 
to the newly formed presynaptic boutons during cLTP 
induction. In contrast, the colocalization extent between 
SYP and NHE6 was significantly decreased in SCAMP5 
KD neurons after cLTP induction (0.132 ± 0.019 in 
+ cLTP of SC5 KD, Fig.  2a–e). Since most of NHE6 
already failed to colocalize with SYP in SCAMP5 KD 
neurons before cLTP induction (0.284 ± 0.017 in − cLTP 
of SC5 KD, Fig.  2a, b, d) [16], our results suggest that 
activity-dependent increase in NHE6 recruitment to the 
pre-existing or newly formed presynaptic terminals is 
completely inhibited in SCAMP5 KD neurons.
cLTP does not increase the quantal size of glutamate 
release at individual presynaptic boutons
We also wondered whether increasing NHE6 recruit-
ment to SVs by cLTP increases the glutamate quantal 
size at individual synapses because the NHE6 recruit-
ment to SVs determines the amount of glutamate uptake 
into SVs, and cation/H+ exchange activity is known to 
augment Δψ to a greater extent than predicted by the 
V-ATPase alone [3]. Thus, the presynaptic quantal size 
would be expected to increase as NHE6 recruitment to 
an individual SVs increases. To address this possibility, 
we used iGluSnFR, a fluorescent glutamate sensor, that 
reflects the amount of glutamate released at individual 
presynaptic boutons [19]. Using iGluSnFR, we have 
recently measured the amount of glutamate released 
spontaneously or in response to a few action potentials 
at the individual presynaptic boutons and such that we 
were able to avoid the postsynaptic interference for quan-
tal size variations. Thus, the only source of quantal size 
variation we could detect with iGluSnFR is presynaptic, 
and the extent of iGluSnFR response is a reliable indica-
tor of the quantal size of glutamate release [16, 21]. The 
amplitude histogram of spontaneous iGluSnFR responses 
was fitted with a single Gaussian distribution (Fig. 3a–c), 
indicating that the unit response was reliably detected. 
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We then co-transfected iGluSnFR along with shRNA 
SCAMP5 or SYP into cultured hippocampal neurons and 
analyzed the amplitude of iGluSnFR signal by spontane-
ously released glutamate before and after cLTP induc-
tion (Fig. 3d, h). We found that the peak intensity of the 
iGluSnFR response to spontaneous glutamate release 
did not change before and after cLTP in control neurons 
(Fig. 3d–g). In SCAMP5 KD, although the amount of glu-
tamate released spontaneously was significantly lower 
than in the control as consistent with our recent results 
Fig. 1 Forskolin-induced cLTP enhances presynaptic activity in cultured hippocampal neurons. a Experimental procedure of imaging and analyzing 
FM 1–43 uptake and destaining after cLTP induction by forskolin or DMSO application. b Representative images of cultured hippocampal neurons 
at DIV14 during FM 1–43 destaining in control (− cLTP) and cLTP-induced (+ cLTP) neurons. Scale bar: 10 μm. c Average fluorescent intensity of FM 
1–43 during destaining period with or without cLTP induction. Traces of individual response (light gray lines) and average trace (thick colored lines) 
of the FM 1–43 signal at presynaptic boutons after treatment of DMSO (− cLTP, n = 170 boutons in 6 coverslips) or forskolin (+ cLTP, n = 167 boutons 
in 6 coverslips). d Turnover extent of FM 1–43 during destaining period. − cLTP, 463.629 ± 51.637 a.u., n = 6 (coverslips); + cLTP, 800.752 ± 61.040 
a.u., n = 6 (coverslips), p = 0.002, analyzed by Student’s t-test. e Normalized average fluorescent intensity of FM 1–43 during destaining period 
with or without cLTP induction. f Time constant (τ) of FM 1–43 intensity during destaining period. − cLTP, 26.871 ± 2.054 s, n = 6 (coverslips); 
+ cLTP, 16.543 ± 0.737 s, n = 6 (coverslips), p = 0.0008, analyzed by Student’s t-test. g Representative images of cultured hippocampal neurons 
co-transfected with DsRed and GFP-synaptophysin (SYP) with or without cLTP induction. Scale bar: 5 μm. h The number of presynaptic boutons per 
10 μm axon. − cLTP, 3.179 ± 0.242 counts/10 μm, n = 6 (coverslips); + cLTP, 4.594 ± 0.411 counts/10 μm, n = 6 (coverslips), p = 0.021, analyzed by 
Student’s t-test. Values are indicated as mean ± SEM. a.u., arbitrary unit. *p < 0.05, **p < 0.01, ***p < 0.001
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[16], the peak intensity of iGluSnFR response also did not 
change after cLTP (Fig.  3h–k), indicating that SCAMP5 
KD inhibited NHE6 localization not only at rest but also 
during cLTP. All these results suggest that despite an 
increase in the number of NHE6-positive boutons by 
cLTP, the amount of glutamate released at individual pre-
synaptic boutons remains unaltered.
Discussion
In this study, we showed that SCAMP5-mediated NHE6 
recruitment to the presynaptic terminals was signifi-
cantly increased during cLTP. Since we recently showed 
that the direct interaction between SCAMP5 and NHE6 
plays a critical role in the recruitment of NHE6 to SVs, 
which regulates the luminal pH of SVs and subsequent 
the amount of neurotransmitter release at glutamater-
gic synapses at rest [16], our current results suggest that 
SCAMP5-mediated NHE6 recruitment is critical for pre-
synaptic regulation of glutamate quantal size not only at 
rest but also during LTP. These results further raised the 
possibility that the enhanced presynaptic recruitment of 
NHE6 by SCAMP5 could be one of the molecular deter-
minants of presynaptically-expressed synaptic plasticity.
We, however, found that despite the increase in NHE6 
recruitment to the presynaptic boutons during cLTP, 
the glutamate quantal size at the individual presynaptic 
Fig. 2 Activity-dependent presynaptic recruitment of NHE6 is completely inhibited by SCAMP5 KD. a Representative images of cultured 
hippocampal neurons co-transfected with BFP-scrRNA or -shRNA SCAMP5, GFP-synaptophysin (SYP) and endogenous NHE6 proteins were 
immunostained (NHE6) after treatment of forskolin (+ cLTP) or DMSO (− cLTP). Scale bar: 5 μm. b Fluorescent intensity profiles of the respective 
protein along the axon. a.u., arbitrary unit. c The number of presynaptic boutons per 10 μm axon. CTL with − cLTP, 3.323 ± 0.251 counts/10 μm, 
n = 10 (coverslips); CTL with + cLTP, 4.282 ± 0.166 counts/10 μm, n = 7 (coverslips); SC5 KD with − cLTP, 3.451 ± 0.274 counts/10 μm, n = 10 
(coverslips); SC5 KD with + cLTP, 4.572 ± 0.429 counts/10 μm, n = 7 (coverslips),  F(3, 30) = 4.354, p = 0.012, analyzed by one-way ANOVA test followed 
by LSD post hoc test. d Manders’ colocalization coefficients of SYP overlapping NHE6. CTL with − cLTP, 0.522 ± 0.039, n = 5 (coverslips); CTL with 
+ cLTP, 0.761 ± 0.037, n = 5 (coverslips); SC5 KD with − cLTP, 0.284 ± 0.017, n = 7 (coverslips); SC5 KD with + cLTP, 0.132 ± 0.019, n = 6 (coverslips), 
 F(3, 19) = 98.777, p = 9.028E−12, analyzed by one-way ANOVA test followed by LSD post hoc test. e Percent change of presynaptic NHE6 localization 
extent after cLTP induction. CTL, + 45.841 ± 7.048%, n = 5 (coverslips); SC5 KD, − 53.451 ± 6.551%, n = 6 (coverslips), p = 2.8E−06, analyzed by 
Student’s t-test. Values are indicated as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001
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Fig. 3 Forskolin-induced cLTP does not change glutamatergic quantal release at individual presynaptic boutons in cultured hippocampal neurons. 
a Representative images of cultured hippocampal neurons co-transfected with DsRed and iGluSnFR. Images of iGluSnFR represent resting condition 
and in the response of glutamate released spontaneously. Scale bar: 5 μm. b Representative traces of the iGluSnFR signal during spontaneous 
glutamate release at one presynaptic bouton. c Amplitude histogram graph of spontaneous iGluSnFR response, n = 135 (boutons). The graph was 
fitted with a single Gaussian distribution. d, h Representative images of cultured hippocampal neurons co-transfected with mCherry-synaptophysin 
(SYP) or DsRed-shRNA SCAMP5, and iGluSnFR. Response signal of iGluSnFR due to spontaneous glutamate release was obtained before and after 
treatment of DMSO or Forskolin, respectively. Scale bar: 5 μm. e, i Representative traces of individual response (thin colored lines) and average trace 
(thick colored lines) of the iGluSnFR signal during spontaneous glutamate release at one presynaptic bouton before and after treatment of DMSO 
or Forskolin, respectively. f, g Changes of normalized peak intensity of iGluSnFR due to spontaneous glutamate release before and after treatment 
of DMSO or Forskolin in control neurons. Before (DMSO), 0.316 ± 0.226 ΔF/F0, n = 20 (boutons, 3 coverslips); After (DMSO), 0.315 ± 0.225 ΔF/F0, 
n = 20 (boutons, 3 coverslips). p = 0.954, Before (Forskolin), 0.322 ± 0.177 ΔF/F0, n = 20 (boutons, 3 coverslips); After (Forskolin), 0.333 ± 0.182 ΔF/F0, 
n = 20 (boutons, 3 coverslips). p = 0.075, analyzed paired samples t-test. j, k Changes of normalized peak intensity of iGluSnFR due to spontaneous 
glutamate release before and after treatment of DMSO or Forskolin in SCAMP5 KD neurons. Before (DMSO), 0.237 ± 0.113 ΔF/F0, n = 24 (boutons, 
3 coverslips); After (DMSO), 0.236 ± 0.104 ΔF/F0, n = 24 (boutons, 3 coverslips). p = 0.772, Before (Forskolin), 0.246 ± 0.129 ΔF/F0, n = 28 (boutons, 
3 coverslips); After (Forskolin), 0.249 ± 0.130 ΔF/F0, n = 28 (boutons, 3 coverslips). p = 0.670, analyzed paired samples t-test. Values are indicated as 
mean ± SD. n.s. non-significance. *p < 0.05, **p < 0.01, ***p < 0.001
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boutons did not change after cLTP (Fig. 3). Several fea-
sible mechanisms can be speculated to explain these 
results. First, the steady-state levels of ΔμH+ across 
the SV membrane can be maintained mainly by the 
V-ATPase. If V-ATPase sets the upper limit of ΔμH+ gen-
erated in the given SV, even if more NHE6 is recruited to 
individual SVs after cLTP induction, no further increase 
in the Δψ, thus the quantal size remained unaffected. 
Second, the presence of NHE6 in SVs might set the lower 
limit of glutamate uptake, and a certain number of NHE6 
in the individual SVs could be sufficient to fully uptake 
glutamate into SVs. It is noteworthy, however, that the 
overexpression of vesicular glutamate transporter 1 is 
known to lead to excess glutamate uptake [27, 28]. In 
addition, an increase in presynaptic cation concentra-
tion above a resting value either artificially or by enhanc-
ing hyperpolarization-activated cyclic nucleotide-gated 
(HCN) channel activation increases the quantal size [4]. 
Both indicate that V-ATPase activity may not be a rate-
limiting step for glutamate uptake into SVs. Furthermore, 
it is known that cation/H+ exchange activity augments 
Δψ to a greater extent than predicted by the V-ATPase 
alone [3]. Thus, the lack of changes in the amount of 
spontaneous glutamate release after cLTP induction 
may indicate that the additional NHE6 is not recruited 
to the presynaptic boutons that already had NHE6. We, 
however, do not rule out the possibility that NHE activ-
ity affects the rate constant for Δψ, thus more NHE6 
only facilitates reaching the steady-state Δψ but does not 
affect the steady-state levels of Δψ. Although intriguing, 
since nothing has been known about the kinetics of NHE 
activity related to V-ATPase activity on Δψ in living cells, 
this certainly requires further study.
We are aware that cLTP in culture conditions can-
not fully reflect what happens during LTP in  vivo, but 
many previous results using cLTP in culture have pro-
vided plenty of significant insights on our understanding 
of synaptic physiology [17, 22, 24] and have later been 
proven to occur similarly in  vivo as well [29–35]. Thus, 
further study is required to find out whether SCAMP5/
NHE6 interaction plays the role during LTP formation or 
maintenance in vivo. Also, LTP primarily has been con-
sidered to involve the postsynaptic phenomena, however, 
various research groups suggested that LTP also induced 
the presynaptic changes including the increased recycling 
pool of SVs, the enhanced release probability, and the 
increased number of presynaptic boutons [17, 18, 22, 24, 
25, 29–35]. We also found that forskolin-induced cLTP 
caused presynaptic changes listed above (Fig. 1), indicat-
ing that forskolin-induced cLTP in cultures reflects most, 
if not all, presynaptic changes caused by LTP in brain 
slices.
Our current results together with our recent find-
ings [16] suggest that SCAMP5 may function directly or 
indirectly with axonal trafficking mechanisms such as 
regulating biophysical properties or the motor proteins, 
post-translational modification of the microtubule, and 
the activation of motor adaptor proteins for controlling 
recruiting-process of the SV proteins to presynaptic ter-
minals. However, the underlying molecular mechanisms 
are currently unknown. Thus, further study for investi-
gating this detailed process is necessary and this will shed 
light on the question about the mechanisms of presyn-
aptic localization of SV proteins that are regulated by 
SCAMP5 or other SCAMPs interaction.
SCAMPs are expressed ubiquitously and reside on 
secretory vesicles for regulating the exocytosis and endo-
cytosis of intracellular recycling vesicles [11], and play a 
role in vesicular trafficking from the trans-Golgi network 
to regulate the recycling process of endosomal compart-
ments [36–42]. One of SV-enriched SCAMPs family, 
SCAMP5, was mainly studied as one of regulators for 
presynaptic function [12, 13], however, it was also pre-
viously reported that SCAMP5 was localized at Golgi-
associated compartments [43, 44] and acts as a facilitator 
of cytokine secretion, and was interacted with synap-
totagmin 1 [44]. This indicates that SCAMP5 may have 
other binding partners at Golgi apparatus in neurons and 
those interactions can regulate vesicular and protein traf-
ficking from Golgi compartments to its cellular destina-
tions for neuronal development or synaptic transmission.
Recent genetic analyses have reported two SCAMP5 
mutations, R91W and G180W. R91W was identified from 
patients with pediatric epilepsy and juvenile PD [14], and 
G180W was identified from patients with ASD, intellec-
tual disability and seizures [45]. The residue of SCAMP5 
R91 and G180 is located in the 2/3 loop and C-terminal 
cytoplasmic domain, respectively, and those SCAMP5 
mutants caused the alteration in protein expression level, 
subcellular distribution, and binding properties com-
pared to those of wild-type SCAMP5, and resulted in the 
neuronal dysfunction with excessive excitatory neuro-
transmission [14]. Especially, since SCAMP5 R91 residue 
is located in the 2/3 loop domain in which NHE6 [16], 
adaptor protein complex 2 (AP-2), and clathrin [13] can 
bind to, the pathological phenotype caused by SCAMP5 
R91W mutant may have resulted from the alteration in 
the extent of protein interaction with its binding part-
ners, followed by the physiological dysfunction from 
defects in neurotransmission. It is certainly of interest 
and requires further study.
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